New Clinical Trials
A multitude of clinical trials are ongoing to investigate the most efficacious treatment for CML, including combination TKI therapy, allogeneic transplant, intrabone cord blood transplant, chemotherapy plus allogeneic transplant, escalating dose imatinib plus interferon alpha or ara-C, and other combinations.
Resources exist for patients to determine if they may be eligible for a clinical trial. The Leukemia and Lymphoma Society’s CML website supports TrialCheck®, an online resource where patients may search for available clinical trial resources that are specific to patients with CML.
Similar searches can be performed at the National Cancer Institute’s clinical trials page.